Statins, known as cholesterol-lowing drugs, appear to be linked to lowering the risk of Alzheimer's disease in certain individuals, as published by a study out on Monday. But not every patient benefited, and the report no longer established the cause and effect. Thus, experts said rigorous clinical trials will have to be done in order to explore the issue some more per Mail Online.
